Cytosorbents Corp reports results for the quarter ended in September 30 - Earnings Summary
08/11/2024 05:14
* Cytosorbents Corp CTSO.OQ reported a quarterly adjusted
loss
of 4 cents per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -21 cents. The mean expectation of
three analysts for the quarter was for a loss of 6 cents per
share. Wall Street expected results to range from -8 cents to -5
cents per share.
* Revenue rose 6.6% to $9.39 million from a year ago;
analysts
expected $10.18 million.
* Cytosorbents Corp's reported EPS for the quarter was a
loss of 4
cents.
* The company reported a quarterly loss of $2.33 million.
* Cytosorbents Corp shares had fallen by 39.8% this
quarter and
lost 18.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 35% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is "hold."
Wall Street's median 12-month price target for Cytosorbents Corp
is 4.00
This summary was machine generated from LSEG data November 8 at
05:14 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.06 -0.04 Beat
Jun. 30 2024 -0.10 -0.08 Beat
Mar. 31 2024 -0.12 -0.12 Met
Dec. 31 2023 -0.14 -0.13 Beat